Altamira Therapeutics to Host Investor Call on September 14th
HAMILTON, Bermuda, Sept. 08, 2022 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced it will hold a call to address questions from investors and discuss the Company’s strategy to become the premier provider of RNA therapeutics.
Related news for (CYTO)
- Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
- Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
- altamira therapeutics provides update on nasdaq listing
- altamira therapeutics announces extended iso 13485 quality management system certification for bentrio nasal spray
- altamira therapeutics provides business update and first half 2024 financial results